Overview

The ENIGMA II Trial:Nitrous Oxide Anaesthesia and Cardiac Morbidity After Major Surgery: a Randomised Controlled Trial

Status:
Completed
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
To investigate the safety of nitrous oxide (N2O) anaesthesia in patients with risk factors for coronary artery disease undergoing major surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Bayside Health
Collaborator:
National Health and Medical Research Council, Australia
Treatments:
Anesthetics
Nitrous Oxide